Endometrial cancer metastatic to infrarenal aortic lymph nodes unrecognized during laparoscopic inframesenteric aortic lymph node dissection

Gynecologic Oncology

Volumn 93, Issue 1, 2004, Pages 260-262

  Eitan, Ram ^a   Abu Rustum, Nadeem R ^a   Walker, Joan L ^b   Barakat, Richard R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Dissection; Endometrial cancer; Lymph node

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; ENDOMETRIUM CARCINOMA; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; INFERIOR MESENTERIC ARTERY; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; LYMPH NODE IRRADIATION; LYMPH NODE METASTASIS; MEDICAL EXAMINATION; OVARY CANCER; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; VAGINAL HYSTERECTOMY;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MESENTERY; MIDDLE AGED; NEOPLASM STAGING;

EID: 1842477741     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.01.003     Document Type: Article

References (10)

1. Spirtos N.M., Schlaerth J.B., Spirtos T.W., Schlaerth A.C., Indman P.D., Kimball R.E. Laparoscopic bilateral pelvic and paraaortic lymph node sampling: an evolving technique. Am. J. Obstet. Gynecol. 173:1995;105-111.
2. Abu-Rustum N.R., Chi D.S., Sonoda Y., DiClemente M.J., Bekker G., Gemignani M.et al. Transperitoneal laparoscopic pelvic and paraaortic lymph node dissection using the argon beam coagulator and monopolar instruments: an 8-year study and description of technique. Gynecol. Oncol. 89(3):2003 (Jun);504-513.
3. Henriksen E. The lymphatic dissemination in endometrial carcinoma: a study of 188 necropsies. Am. J. Obstet. Gynecol. 123:1975;204-208.
4. Mariani A., Webb M.J., Keeney G.L., Podratz K.C. Routes of lymphatic spread: a study of 112 patients with endometrial cancer. Gynecol. Oncol. 81:2001;100-104.
5. Creasman W.T., Morrow C.P., Bundy B.N., Homseley H.D., Graham J.E., Heller P.B. Surgical pathologic spread patterns of endometrial cancer. Cancer. 60:1987;2035-2041.
6. Hirahatake K., Hareyama H., Saguraki N., Nishiya M., Makinoda S., Fujimoto S. A clinical and pathological study on para-aortic lymph node metastasis in endometrial carcinoma. J. Surg. Oncol. 65:1997;82-87.
7. McMeekin D.S., Lashbrook D., Gold M., Scribner D.R., Kamelle S., Tillmans T.D.et al. Nodal distribution and its significance in FIGO stage IIIc endometrial cancer. Gynecol. Oncol. 82:2001;375-379.
8. Hsieh C.H., ChuangChien C.C., Lin H., Huang E.Y., Huang C.C., Lan K.C.et al. Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer? Gynecol. Oncol. 86:2002;28-33.
9. Burke T.W., Levenback C., Tornos C., Morris M., Wharton J.T., Gershenson D.M. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol. Oncol. 62:1996;169-173.
10. Alektiar K.M., McKee A., Lin O., Venkatraman E., Zelefsky M., Mckee B.et al. Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO grade 3 cancer? Int. J. Radiat. Oncol. Biol. Phys. 54:2002;79-85.